Full Text View
Tabular View
No Study Results Posted
Related Studies
Atorvastatin in Relapsing-Remitting Multiple Sclerosis
This study has been completed.
Study NCT00616187   Information provided by Charite University, Berlin, Germany

First Received on February 5, 2008.   Last Updated on February 14, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Sclerosis
More general conditions related to this trial
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Demyelinating Autoimmune Diseases, CNS
Demyelinating Diseases
Immune System Diseases
Nervous System Diseases
Pathologic Processes
Interventions listed in this trial
untreated to atorvastatin treatment
Additional drug interventions recognized in this trial
Atorvastatin
Interferon-beta
Interferons
More general drug interventions related to this trial
Anti-Infective Agents
Anticholesteremic Agents
Antimetabolites
Antineoplastic Agents
Antiviral Agents
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Immunologic Factors
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Charite University, Berlin, Germany
German Research Foundation
German Federal Ministry of Education and Research
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services